The Key to Finding the Right Leader is Knowing our Clients.
We have been privileged to partner with initial start-ups, development stage companies and global leaders in the life sciences sector. Each client brings unique and compelling aspects, and we have developed an outstanding ability to find the right candidates who fit best with their needs.
Clients
- Adis International, Ltd. (now WKLSG)
- Adolor Corporation
- Advanced Tissue Sciences, Inc.
- Albany Molecular Research, Inc.
- AlgoRx Pharmaceuticals, Inc. (now Anesiva)
- Algos Therapeutics, Inc. (now Endo)
- Alpha Therapeutic Corporation (now Grifols)
- ALZA Corporation (now J&J)
- American Type Culture Collection
- Amicus Therapeutics, Inc.
- Applied Immune Sciences, Inc. (now Sanofi-Aventis)
- Arena Pharmaceuticals, Inc.
- AriZeke Pharmaceuticals, Inc.
- Armour Pharmaceutical Co. (now CSL Behring)
- Avalon Pharmaceuticals, Inc. (now Clinical Data Inc.)
- Avanir Pharmaceuticals, Inc.
- Bayer Healthcare Pharmaceuticals, Inc.
- BioChem Pharma, Inc.
- BMP Corp
- Cadence Pharmaceuticals, Inc.
- Celator Pharmaceuticals, Inc.
- Cell Genesys, Inc.
- Cell Therapeutics, Inc.
- Centocor, Inc. (division of Johnson & Johnson)
- Cephalon, Inc.
- Ceregene, Inc.
- CFY BioMedicals, Inc. (later renamed Perlan Therapeutics)
- Chugai Pharmaceutical Co., Ltd. (now Roche Group)
- CIMA Labs, Inc. (now Cephalon)
- CoCensys, Inc. (now Purdue)
- Coley Pharmaceutical Group, Inc. (now Pfizer)
- Conforma Therapeutics Corporation (now Biogen Idec)
- Connetics Corporation (now Stiefel)
- Corixa Corporation (now GSK)
- Corning Hazelton, Inc. (now Corning Life Sciences)
- Corvas International, Inc. (now Dendreon Corporation)
- Coulter Pharmaceuticals, Inc. (now GSK)
- CpG Immuno Pharmaceuticals, Inc
- Curagen Corporation
- Cytogen Corporation
- Delsys, Inc. (now Elan)
- Delta Technology, Ltd.
- Deltagen, Inc. (now Pfizer)
- Dermik Laboratories, Inc. (now Sanofi-Aventis)
- Dura Pharmaceuticals, Inc. (now Elan)
- Enchira Biotechnology Corporation
- Enzon, Inc.
- Epix Pharmaceuticals, Inc.
- Faulding, Inc. (now Hospira)
- Genoptix, Inc.
- GenStar Therapeutics Corporation (now VIA Pharmaceuticals)
- Genzyme Corporation
- IBAH, Inc. (now Omnicare)
- ICN Pharmaceuticals, Inc. (now Valeant Pharmaceuticals)
- Immunization Products, Ltd.
- InfiMed Therapeutics
- iScience Interventional, Corporation
- Isis Pharmaceuticals, Inc.
- JRH Biosciences, Inc. (now Sigma Aldrich)
- Koronis Pharmaceuticals, Inc.
- La Jolla Pharmaceutical Company
- Mallinckrodt Medical, Inc. (now Covidien)
- MedImmune, Inc.
- MedPointe, Inc. (now Meda)
- Molecular Insight Pharmaceuticals, Inc.
- Myriad Genetics, Inc.
- Nanogen, Inc.
- NeurogesX, Inc.
- New River Pharmaceuticals, Inc. (now Shire)
- Noramco, Inc. (part of Johnson & Johnson)
- NPS Pharmaceuticals, Inc.
- Onyx Pharmaceuticals, Inc.
- Optimer Pharmaceuticals, Inc.
- Pan Pacific Pharmaceuticals, Inc.
- Paratek Pharmaceuticals, Inc.
- Pharmacia Corporation (now Pfizer)
- PharmaCore, Inc.
- PharmaCyclics, Inc.
- PharmaKinetics Laboratories, Inc.
- Pharmion Corporation (now Celgene)
- Phytomedics, Inc.
- polyGenomics, Inc. (now Qiagen)
- RadPharm, Inc.
- Repligen Corporation
- Reva Medical, Inc.
- Rhone-Poulenc Rorer, Inc. (now Sanofi-Aventis)
- Ross Products, Inc. (now Abbott Nutrition)
- RPR-Gencell
- Salmedix, Inc. (now Cephalon)
- Santarus, Inc.
- Schein Pharmaceuticals, Inc. (now Watson Laboratories)
- Selective Genetics, Inc.
- Sepracor, Inc.
- SGX Pharmaceuticals, Inc. (now Pfizer)
- SkinMedica, Inc.
- SmithKline Beecham Corporation (now GlaxoSmithKline)
- Sonus Pharmaceuticals(now OncoGenex Pharmaceuticals)
- SRI International, Inc.
- Sugen, Inc. (now Pfizer)
- Suntory Pharmaceutical Research Laboratories, LLC.
- The Macroflux Corporation (now Zosano, Inc.)
- VaxInnate Corporation
- Verion, Inc.
- Versicor, Inc. (now Pfizer)
- Viasys Healthcare, Inc. (now Cardinal Health)
- Vical, Inc.
- ViroPharma, Inc.
- VivoMetrics, Inc.
- Zeneca, Inc. (now AstraZeneca)
Delsys, Inc. (now Elan)
Delsys Pharmaceutical Corporation was a development stage start-up company focused on revolutionizing the Pharmaceutical Manufacturing Industry with an automated manufacturing process that eliminates most of the costly procedures presently used in the Pharmaceutical Industry, primarily as it pertains to tablet manufacturing. The company uses a proprietary dry-powder deposition and release technology, first developed by the David Sarnoff Research Center, Inc., to create unprecedented dose-delivery formats using only pure active compounds. Delsys was acquired by Elan.
Search Projects
- Vice President, Operations
- Vice President, Research and Development
- Senior Director, Regulatory Affairs
- Director, Formulations
- Director, Regulatory Affairs